Covid-19 Infection and Long-term Cardiovascular Symptoms

NCT05715879 | Completed DMC

• 1 other identifier: IR.SUMS.MED.REC.1401.465
• Study Type: observational
• Target: 879
• Locations: 1 country
• Sites: 1

Brief Summary

From the registry of professor Kojuri clinic , those with Covid-19 infection were selected and was contacted and asked about the cardiovascular symptoms, 1 year after the covid infection

Conditions

COVID-19 Pandemic; Dyspnea; Cardiac; Chest Syndrome; Functional Cardiac Disorder

Keywords

Atherosclerosis; covid-19; dyspnea; chest pain

Outcome Measures

Primary Outcomes (3)

• dyspnea

  Abnormal shortness of breath with lower activities or at rest

  1 year

• chest pain

  cheat pain mimicking angina

  1 year

• MACE

  major adverse cardiac events, myocardial infarction, admission, death or nead for revascularization

  1 year

Secondary Outcomes (1)

• fatigue

  1 year

Study Arms (1)

diseased

covid infection patients

Diagnostic Test: covid infection; Biological: admission to hispital

Interventions

covid infection DIAGNOSTIC_TEST

patients with covid infection which was proved with positive test

Also known as: covid 19 infection

diseased

admission to hispital BIOLOGICAL

patients with sever covid disease, who was admitted in hospital

diseased

Eligibility Criteria

• Age: 15 Years - 78 Years
• Sex: all
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

The study population was patients referring to Professor Kojuri Cardiovascular Clinic in Shiraz, Iran (email: kojurij@yahoo.com, webpage: http://kojuriclinic.com). A database of patients' information is available, including underlying diseases, signs and symptoms, medications, laboratory tests, electrocardiography, and echocardiography. The data is documented by expert cardiologists on every patient's visit.

You may qualify if:

• COVID-19 infection confirmed by PCR or suggested by HRCT findings and having been afflicted with COVID-19 at least one year ago

You may not qualify if:

• COVID-19 infection, which occurred less than a year ago,
• probable history of COVID-19 not confirmed by PCR or HRCT

Sponsors & Collaborators

• Shiraz University of Medical Sciences: lead

Study Sites (1)

Cardiology Ward Shiraz University of Medical Sciences

Shiraz, Fars, 51318, Iran

Location

Related Publications (1)

• Golchin Vafa R, Heydarzadeh R, Rahmani M, Tavan A, Khoshnoud Mansorkhani S, Zamiri B, Amiri F, Azadian A, Khademolhosseini A, Montaseri M, Hosseini N, Hosseini SA, Kojuri J. The long-term effects of the Covid-19 infection on cardiac symptoms. BMC Cardiovasc Disord. 2023 Jun 6;23(1):286. doi: 10.1186/s12872-023-03322-8.

  PMID: 37280530 DERIVED

MeSH Terms

Conditions

COVID-19; Dyspnea; Atherosclerosis; Chest Pain

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases; Respiration Disorders; Signs and Symptoms, Respiratory; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Arteriosclerosis; Arterial Occlusive Diseases; Vascular Diseases; Cardiovascular Diseases; Pain; Neurologic Manifestations

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: PROSPECTIVE
• Target Duration: 365 Days
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: professor

Study Record Dates

• First Submitted: February 4, 2023
• First Posted: February 8, 2023
• Study Start: October 1, 2020
• Primary Completion: May 1, 2021
• Study Completion: May 1, 2021
• Last Updated: May 1, 2023

Record last verified: 2023-04

Locations

IR (1)